Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTCH2P3 is a processed pseudogene derived from the MTCH2 gene, which encodes a mitochondrial outer membrane protein involved in apoptosis, mitochondrial fusion, and metabolic regulation[1][3][4]. Unlike its parent gene MTCH2, MTCH2P3 does not code for a functional protein and is not known to participate in any biological processes, serve as a therapeutic target, or be associated with disease roles. Pseudogenes like MTCH2P3 generally lack transcriptional activity and functional protein products, and thus are not considered therapeutic targets. Sometimes, pseudogenes may exert regulatory effects on their parent genes via RNA mechanisms, but there is no evidence in the literature that MTCH2P3 does so. Key clarification: - MTCH2P3 is not a receptor, transporter, enzyme, or any functional molecule—it is a pseudogene and should be excluded from therapeutic target databases. - If you intended to refer to MTCH2, the mitochondrial carrier homolog 2 (sometimes called MIMP or SLC25A50), that is an active protein with roles in apoptosis, metabolism, and disease[1][3][4]. However, MTCH2P3 itself has no such functions. Summary of correctness: - MTCH2P3 is not a valid therapeutic target; it is a pseudogene, and document sources give no functional or disease-related information for this entry. - If the query is meant for the functional MTCH2 protein, refer to "Mitochondrial carrier homolog 2 (MTCH2)," not MTCH2P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial carrier homolog 2 pseudogene 3 (MTCH2P3).